| Basics |
|
Twist Bioscience Corporation
|
| IPO Date: |
October 29, 2018 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.98B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.71 | 3.38%
|
| Avg Daily Range (30 D): |
$0.90 | 3.09%
|
| Avg Daily Range (90 D): |
$0.86 | 2.78%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.7M |
| Avg Daily Volume (30 D): |
1.57M |
| Avg Daily Volume (90 D): |
1.28M |
| Trade Size |
| Avg Trade Size (Sh.): |
55 |
| Avg Trade Size (Sh.) (30 D): |
59 |
| Avg Trade Size (Sh.) (90 D): |
54 |
| Institutional Trades |
| Total Inst.Trades: |
3,276 |
| Avg Inst. Trade: |
$3.38M |
| Avg Inst. Trade (30 D): |
$4M |
| Avg Inst. Trade (90 D): |
$3.31M |
| Avg Inst. Trade Volume: |
.08M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.28M |
| Avg Closing Trade (30 D): |
$7.13M |
| Avg Closing Trade (90 D): |
$6.02M |
| Avg Closing Volume: |
124.04K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-1.44
|
$.34
|
$-.66
|
|
Diluted EPS
|
$-1.44
|
$.33
|
$-.66
|
|
Revenue
|
$ 362.27M
|
$ 96.06M
|
$ 92.79M
|
|
Gross Profit
|
$ 178.4M
|
$ 51.3M
|
$ 46.03M
|
|
Net Income / Loss
|
$ -85.19M
|
$ 20.39M
|
$ -39.33M
|
|
Operating Income / Loss
|
$ -142.37M
|
$ -30.12M
|
$ -41.56M
|
|
Cost of Revenue
|
$ 183.88M
|
$ 44.76M
|
$ 46.77M
|
|
Net Cash Flow
|
$ -38.13M
|
$ -9.04M
|
$ -11.11M
|
|
PE Ratio
|
|
|
|
|
|
|